Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis
Authors:
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 172 (3) , 1132-1138
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Endothelial Cell Production of Nitrogen Oxides in Response to Interferon in Combination With Tumor Necrosis Factor, Interleukin-1, or EndotoxinJNCI: Journal of the National Cancer Institute, 1990
- Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.Journal of Experimental Medicine, 1989
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shockEuropean Journal of Pharmacology, 1987
- The relative role of PAF-acether and icosanoids in septic shockPharmacological Research Communications, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Elevated plasma 6-keto-prostaglandin F1α in patients in septic shockCritical Care Medicine, 1985
- N-methylated arginines; A convenient preparation of N-methylarginineAnalytical Biochemistry, 1974